Circulating levels of IL-1β, a prothrombotic cytokine, are elevated in unstable angina versus stable angina

Journal of Thrombosis and Thrombolysis

Volumn 9, Issue 3, 2000, Pages 217-222

  Simon, Alan D ^a   Yazdani, Shahram ^a   Wang, Weizheng ^a   Schwartz, Allan ^a   Rabbani, LeRoy E ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Interleukins; Stable angina; Unstable angina

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

EID: 0034035895     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018758409934     Document Type: Article

References (36)

1. Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 1991;88(3):836-844.
2. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;90(1):36-44.
3. Serneri GGN, Prisco D, Martini F, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95 (7):1806-1812.
4. Liuzzo G, Biasucci LM, Gallimore R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med 1994;331(7):417-424.
5. Mazzone A, De Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unsta-ble coronary artery disease. Circulation 1993;88(2):358-363.
6. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arteriosc, Thromb, & Vasc Biol 1992;16(8):1000-1006.
7. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990;65:297-302.
8. Kanda T, Hirao Y, Oshima S, et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 1996;77(Feb 1):304-307.
9. Biasucci LN, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;95(5): 874-877.
10. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased section of tumor necrosis factor-α and interferon-α by mononuclear leukocytes in patients with ischemic heart disease. Circulation 1994;90(2):694-699.
11. Blum A, Sclarovsky S, Shohat B. T-lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91(1):20-22.
12. Maseri A. Inflammation, atherosclerosis, and ischemic events - Exploring the hidden side of the moon. New Engl J Med 1997;336:1014-1015.
13. Dinarello C. Biologic basis for interleukin-1 in disease. Blood 1996;87(6):2095-2147.
14. Dinarello CA. Interleukin-1. Adv Pharmacol 1994;25:21-51.
15. Tracey KJ, Cerami A. Tumor Necrosis Factor: A pleitropic cytokine and therapeutic target. Ann Rev Med 1994;45: 491-503.
16. Dejana E, Brevario F, Erroi A, et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 1987;69:695-699.
17. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exper Med 1989;169:2133-2148.
18. Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T. B cell stimulating factor 2 / interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exper Med 1988;167:1253-1258.
19. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988;332:83-84.
20. Van der Meer J, Helle M, Aarden L. Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection. Eur J Immunol 1989;19:413-416.
21. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon beta 2 / B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proceedings of the National Academy of Science 1987;84:7251-7255.
22. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [see comments] [published erratum appears in N Engl J Med 1997 Jul 31;337(5):356].N Engl J Med 1997;336(14):973-979.
23. Van der Poll T, Levi M, Hack CE, ten Cate H, Van Deventer SJH, Eerenberg AJM. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exper Med 1994;179:1253-1259.
24. Stouthard J, Levi M, Hack E, Veenhif C, Romijin H, Sauerwein H. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb & Haemos 1996;76:738-742.
25. Neumann F, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755.
26. Sterpetti AV, Cucina A, Morena AR, et al. Shear stress increases the release of interleukin-1 and interleukin-6 by aortic endothelial cells. Surgery 1994;114:911-914.
27. Thomas CE, Jackson RL, Ohleiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1β release from human blood mononuclear cells. Lipid Res 1994;35:417-427.
28. Ku G, Doherty NS, Schmidt LF, Jackson RL, Dinerstein RJ. Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties. FASEB J 1990;4:1645.
29. Apostolopoulos J, Davenport P, Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Arteriosc, Thromb, & Vasc Biol 1996;16(8):1007-1012.
30. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin-8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 1996;271(15):8837-8842.
31. Hasadi D, Scheinowitz M, Leibovitz E, Sclorovsky S, Eldan M, Barak V. Increased concentrations of interleukin-1β in patients with coronary artery disease. Heart 1996;76:24-28.
32. Coletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Cambell DA. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfu-sion injury in the rat. J Clin Invest 1990;85(6):1936-1943.
33. Gearing AJH, Beckett P, Christodoulou M, et al. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 1994;370(6490):555-557.
34. Ferrari R, Bachetti T, Cunfortini R, et al. Tumor necrosis factor receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-1486.
35. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol 1989;143 (12):4015-4018.
36. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production. J Exper Med 1991;174(4):785-790.